No abstract available
Keywords:
CORE; COVID‐19; SARS‐CoV‐2; autonomic dysfunction; corona rhombencephalopathy; myoclonus; parainfectious.
PubMed Disclaimer
Conflict of interest statement
The authors did not receive funding for this manuscript. The authors declare that there are no conflicting interests concerning this manuscript. The authors declare that there are no additional disclosures to report.
References
-
-
Schellekens MMI, Bleeker‐Rovers CP, Keurlings PAJ, Mummery CJ, Bloem BR. Reversible myoclonus‐ataxia as a Postinfectious manifestation of COVID‐19. Mov Disord Clin Pract 2020;7:977–914.
-
PMC
-
PubMed
-
-
Latorre A, Rothwell JC. Myoclonus and COVID‐19 : A challenge for the present, a lesson for the future. Mov Disord Clin Pract 2020;7:888–890.
-
PMC
-
PubMed
-
-
Rábano‐Suárez P, Bermejo‐Guerrero L, Méndez‐Guerrero A, et al. Generalized myoclonus in COVID‐19. Neurology 2020;95:e767–e772.
-
PMC
-
PubMed
-
-
Logmin K, Karam M, Schichel T, Harmel J, Wojtecki L. Non‐epileptic seizures in autonomic dysfunction as the initial symptom of COVID‐19. J Neurol 2020;267:2490–2491.
-
PMC
-
PubMed
-
-
Chen T, Hanna J, Walsh EE, Falsey AR, Laguio‐Vila M, Lesho E. Syncope, near syncope, or nonmechanical falls as a presenting feature of COVID‐19. Ann Emerg Med 2020;76:115–117.
-
PMC
-
PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous